Aralez Pharmaceuticals, Inc. merges with Pozen, Inc.

On February 5, 2016, Aralez Pharmaceuticals, Inc. merged with Pozen, Inc., a life science company in North Carolina, United States.

Deal at a glance

AnnouncedFebruary 5, 2016 TypeMerger TargetPozen, Inc. Buyer Aralez Pharmaceuticals, Inc. SectorLife Science LocationNorth Carolina, United States ValueNot disclosed

Target company

Pozen, Inc.

North Carolina, United States

Life Sciencesector

-founded

Activestatus

View the company profile →

Buyer

Aralez Pharmaceuticals, Inc.

Company · 4 deals on record

1st transaction in life science
1st transaction in United States

4deals, all time

3in this sector

2016latest

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026

ArtesRx LLCSame sector and country · Aug 2026

Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Pozen, Inc.?Aralez Pharmaceuticals, Inc. merged with Pozen, Inc. on February 5, 2016.

What type of deal was it?It was a merger in the life science sector in 2016.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).